Here are the 8-K filings from Electra Therapeutics, Inc. (ETRA) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An 8-K covers material events a company has to report between its quarterly reports, so if you follow ETRA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ETRA filings page.
Electra Therapeutics, Inc. (ETRA) reported the closing of its initial public offering of common stock on September 21, 2026. The company sold 23,333,334 shares of common stock at $15.00 per share, generating approximately $350.0 million in gross proceeds before underwriting discounts and expenses.
In connection with the IPO closing, Electra Therapeutics’ stockholders and board put into effect an amended and restated certificate of incorporation and amended and restated bylaws. The company’s common stock trades on The Nasdaq Global Select Market under the symbol ETRA.